FDA Inspection 750585 — Cipla Limited

Cipla Limited — FEI 3007021905

The FDA completed an inspection of Cipla Limited on September 22, 2011 in Mumbai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 22, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Mumbai (India)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
891221 CFR 314.81(b)(2)Timely submission